• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: W. L. GORE & ASSOCIATES, INC. GORE VIABAHN ENDOPROSTHESIS WITH HEPARIN BIOACTIVE SURFACE; STENT, SUPERFICIAL FEMORAL ARTERY

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

W. L. GORE & ASSOCIATES, INC. GORE VIABAHN ENDOPROSTHESIS WITH HEPARIN BIOACTIVE SURFACE; STENT, SUPERFICIAL FEMORAL ARTERY Back to Search Results
Model Number VBJR060702A
Device Problem Activation Failure (3270)
Patient Problems Failure of Implant (1924); Perforation (2001)
Event Date 09/16/2020
Event Type  Injury  
Manufacturer Narrative
Review of device manufacturing record history confirmed device met pre-release specifications.Additional manufacturer narrative: cbas® heparin surface incorporates cbas-heparin manufactured from heparin sodium api, which is covalently bound to the device surface and is essentially non-eluting.
 
Event Description
During treatment of a superficial femoral artery, the physician attempted to deploy a gore® viabahn® endoprosthesis (viabahn device).As reported, the deployment line was fully deployed and removed but the viabahn device remained partially constrained.From the distal end, the physician attempted to balloon the constrained section but this was not possible.As a result, a cut down was made at the popliteal artery (above knee) in order to remove the viabahn device.To complete the procedure, a longer viabahn device was then advanced and deployed with no issues.
 
Manufacturer Narrative
H6 - code 213: engineering evaluation states the following items were returned: the following items were returned and reviewed: 51.5cm of the delivery catheter, including the distal shaft, distal tip, deployment line, deployment knob, and partially deployed device.The evaluation confirms the complaint of partial deployment and finds the cause to be tensile failure of the deployment line.The ultimate cause of the broken deployment line cannot be further identified because deployment was able to be continued in the lab.A product history review was conducted for the viabahn stent graft.The manufacturing records were reviewed, and the device lot met all pre-release specifications.H6 - codes were updated.
 
Manufacturer Narrative
D1 - product name was corrected.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
GORE VIABAHN ENDOPROSTHESIS WITH HEPARIN BIOACTIVE SURFACE
Type of Device
STENT, SUPERFICIAL FEMORAL ARTERY
Manufacturer (Section D)
W. L. GORE & ASSOCIATES, INC.
1505 n. fourth street
flagstaff AZ 86004
MDR Report Key10657788
MDR Text Key210676389
Report Number2017233-2020-01343
Device Sequence Number1
Product Code NIP
UDI-Device Identifier00733132624096
UDI-Public00733132624096
Combination Product (y/n)Y
PMA/PMN Number
P040037
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative
Type of Report Initial,Followup,Followup
Report Date 04/06/2021
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date06/23/2022
Device Model NumberVBJR060702A
Device Catalogue NumberVBJR060702A
Initial Date Manufacturer Received 09/16/2020
Initial Date FDA Received10/09/2020
Supplement Dates Manufacturer Received09/16/2020
09/16/2020
Supplement Dates FDA Received03/09/2021
04/06/2021
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
Patient Age55 YR
-
-